-
公开(公告)号:US20180273575A1
公开(公告)日:2018-09-27
申请号:US15994378
申请日:2018-05-31
IPC分类号: C07H19/20 , C07H1/00 , C07H19/16 , B01J27/128 , B82Y20/00
CPC分类号: C07H19/20 , B01J27/128 , B82Y20/00 , C07H1/00 , C07H19/06 , C07H19/10 , C07H19/16 , H01S5/34326
摘要: A process for preparing phosphoramidates of nucleosides where a desired enantiomer, having regard to the asymmetric chiral center of the phosphorus atom P, is provided in an enriched amount. The process comprises admixing a nucleoside with a phosphorochloridate in the presence of a catalyst comprising a metal salt selected from the group consisting of salts of Cu, Fe, La and Yb.
-
公开(公告)号:US10005810B2
公开(公告)日:2018-06-26
申请号:US14442987
申请日:2013-11-15
IPC分类号: C07H19/20 , C07H19/173 , A01N43/04 , A61K31/70 , C07H1/00 , C07H19/06 , C07H19/16 , B82Y20/00 , B01J27/128 , C07H19/10 , H01S5/343
CPC分类号: C07H19/20 , B01J27/128 , B82Y20/00 , C07H1/00 , C07H19/06 , C07H19/10 , C07H19/16 , H01S5/34326
摘要: Provided are phosphoramidate nucleoside compounds of Formula (I), or pharmaceutically acceptable salts or esters or solvates thereof, useful in the treatment of cancer, viral infections and other diseases: Also provided is a process for the synthesis of the compounds of Formula (I) where a desired enantiomer, having regard to the asymmetric chiral center of the phosphorus atom P, is provided in an enriched amount. The process comprises admixing a nucleoside with a phosphorochloridate in the presence of a catalyst comprising a metal salt selected from the group consisting of salts of Cu, Fe, La and Yb.
-
公开(公告)号:US20150291650A1
公开(公告)日:2015-10-15
申请号:US14442987
申请日:2013-11-15
IPC分类号: C07H19/20 , C07H19/10 , B01J27/128 , C07H1/00
CPC分类号: C07H19/20 , B01J27/128 , B82Y20/00 , C07H1/00 , C07H19/06 , C07H19/10 , C07H19/16 , H01S5/34326
摘要: Provided is a process for preparing phosphoramidates of nucleosides where a desired enantiomer, having regard to the asymmetric chiral center of the phosphorus atom P, is provided in an enriched amount. The process comprises admixing a nucleoside with a phosphorochloridate in the presence of a catalyst comprising a metal salt selected from the group consisting of salts of Cu, Fe, La and Yb.
摘要翻译: 提供了制备核苷的氨基磷酸酯的方法,其中考虑到磷原子P的不对称手性中心以富集的量提供所需的对映异构体。 该方法包括在包含选自Cu,Fe,La和Yb的盐的金属盐的催化剂存在下将核苷与氯代氯酸酯混合。
-
-